登录 | 注册    关注公众号  
微信公众号
搜索
 >  Cell>TSHR >SCCHO-ATP085

CHO/Human TSHR Stable Cell Line Development Service

For research use only.

描述(Description)

The CHO/Human TSHR Stable Cell Line was engineered to express the receptor full length human TSHR (Gene ID: 7253). Surface expression of human TSHR was confirmed by flow cytometry.

应用说明(Application)

• Useful for cell-based TSHR binding assay

生长特性(Growth Properties)

Adherent

筛选标记(Selection Marker)

Hygromycin (20 μg/mL)

培养基(Culture Medium)

F-12K + 10% FBS

冻存液(Freeze Medium)

Serum-free cell cryopreservation medium

装量(Quantity)

1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

存储(Storage)

Frozen in liquid nitrogen.

支原体检测(Mycoplasma Testing)

Negative

无菌检测(Sterility Testing)

Negative

使用说明(Instructions for Use)

See data sheet for detailed culturing and assay protocol.

 

Receptor Assay

TSHR FACS

Expression analysis of human TSHR on CHO/Human TSHR Stable Cell Line by FACS.
Cell surface staining was performed on CHO/Human TSHR Stable Cell Line or negative control cell using anti-human TSHR Antibody followed by staining with PE anti-human IgG Fc Antibody.

Protocol

如有相关细胞池需求请联系我们

 

背景(Background)

The protein encoded by this gene is a membrane protein and a major controller of thyroid cell metabolism. The encoded protein is a receptor for thyrothropin and thyrostimulin, and its activity is mediated by adenylate cyclase. Defects in this gene are a cause of several types of hyperthyroidism. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]

 

License Disclosure

This cell line is provided for research use only. This license does not permit you to share, distribute, sell, sublicense, or otherwise make this cell line available for use to other laboratories, departments, research institutions, hospitals, universities, or biotech companies. The license does not permit modification of this cell line in any way. Inappropriate use or distribution of this cell line will result in revocation of the license. Modifications of this cell line, transfer to another facility, or commercial use of the cell lines may require a separate license and additional fees. AcroBiosystems does not warrant the suitability of this cell line for any particular use, and does not accept any liability in connection with the handling or use of this cell line.

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
TSHR靶点信息
英文全称:Thyroid stimulating hormone receptor
中文全称:促甲状腺激素受体
种类:Homo sapiens
上市药物数量:1详情
临床药物数量:3详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定